Parallax Volatility Advisers’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-275
Closed -$3.83K 2994
2023
Q1
$3.69K Sell
275
-10,955
-98% -$190K ﹤0.01% 2517
2022
Q4
$139K Sell
11,230
-10,560
-48% -$150K ﹤0.01% 2212
2022
Q3
$304K Buy
+21,790
New +$351K ﹤0.01% 2171
2022
Q1
Sell
-125,000
Closed -$2.04M 3338
2021
Q4
$2.04M Sell
125,000
-16
-0% -$270 ﹤0.01% 1078
2021
Q3
$1.86M Buy
+125,016
New +$2M ﹤0.01% 1143
2021
Q1
Sell
-50,638
Closed -$1.25M 2248
2020
Q4
$1.25M Buy
50,638
+33,968
+204% +$1.13M ﹤0.01% 1380
2020
Q3
$691K Buy
16,670
+1,662
+11% +$76.4K ﹤0.01% 2137
2020
Q2
$719K Buy
15,008
+5,090
+51% +$393K ﹤0.01% 1863
2020
Q1
$624K Buy
9,918
+9,755
+5,985% +$877K ﹤0.01% 1637
2019
Q4
$20K Sell
163
-5,538
-97% -$496K ﹤0.01% 2290
2019
Q3
$378K Buy
5,701
+2,109
+59% +$142K ﹤0.01% 1689
2019
Q2
$286K Buy
3,592
+1,655
+85% +$148K ﹤0.01% 1656
2019
Q1
$217K Buy
1,937
+1,107
+133% +$121K ﹤0.01% 1860
2018
Q4
$84K Buy
+830
New +$86K ﹤0.01% 1982
2018
Q3
Sell
-181
Closed -$19.2K 3810
2018
Q2
$15K Buy
+181
New +$13.3K ﹤0.01% 1711
2018
Q1
Sell
-2,233
Closed -$130K 4635
2017
Q4
$130K Buy
+2,233
New +$141K ﹤0.01% 2618
2016
Q1
Sell
-471
Closed -$70K 3938
2015
Q4
$70K Buy
+471
New +$79.7K ﹤0.01% 2240

Other funds holding ICPT

Parallax Volatility Advisers's ICPT Position: Q2 2023 in Review

Parallax Volatility Advisers sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2023, closing a stake of 275 shares — an estimated $3.83K sold.

Parallax Volatility Advisers first reported a position in ICPT in Q4 2015 and held it in 17 quarters. The position peaked at $2.04M in Q4 2021. 126 funds tracked by Wall St. Rank hold ICPT as of Q2 2023.

  • Parallax Volatility Advisers reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Parallax Volatility Advisers sold 275 Intercept Pharmaceuticals, Inc. shares in Q2 2023, an estimated $3.83K.
  • Parallax Volatility Advisers first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2015 and held it in 17 quarters.
  • Parallax Volatility Advisers's Intercept Pharmaceuticals, Inc. position peaked at $2.04M in Q4 2021.
  • 126 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2023.

Based on Parallax Volatility Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.